 | Up a level |
2022
Horgan, Denis, Curigliano, Giuseppe 
ORCID: 0000-0003-1781-2518, Riess, Olaf, Hofman, Paul ORCID: 0000-0003-0431-9353, Buettner, Reinhard, Conte, Pierfranco, Cufer, Tanja, Gallagher, William M., Georges, Nadia, Kerr, Keith, Penault-Llorca, Frederique, Mastris, Ken ORCID: 0000-0002-6074-8147, Pinto, Carla, Van Meerbeeck, Jan, Munzone, Elisabetta, Thomas, Marlene, Ujupan, Sonia, Vainer, Gilad W. ORCID: 0000-0002-8828-8138, Velthaus, Janna-Lisa and Andre, Fabrice
(2022).
Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
J. Pers. Med., 12 (1).
BASEL:
MDPI.
ISSN 2075-4426
2017
Nogova, Lucia, Sequist, Lecia V., Garcia, Jose Manuel Perez, Andre, Fabrice, Delord, Jean-Pierre, Hidalgo, Manuel, Schellens, Jan H. M., Cassier, Philippe A., Camidge, D. Ross, Schuler, Martin, Vaishampayan, Ulka ORCID: 0000-0001-5800-4571, Burris, Howard, Tian, G. Gary, Campone, Mario, Wainberg, Zev A., Lim, Wan-Teck ORCID: 0000-0002-4655-0206, LoRusso, Patricia, Shapiro, Geoffrey I., Parker, Katie, Chen, Xueying, Choudhury, Somesh, Ringeisen, Francois, Graus-Porta, Diana, Porter, Dale, Isaacs, Randi, Buettner, Reinhard and Wolf, Juergen
(2017).
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.
J. Clin. Oncol., 35 (2).
S. 157 - 176.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2014
Miller, Kathy D., Dieras, Veronique, Harbeck, Nadia, Andre, Fabrice, Mahtani, Reshma L., Gianni, Luca, Albain, Kathy S., Crivellari, Diana, Fang, Liang, Michelson, Glenn, de Haas, Sanne L. and Burris, Howard A. (2014). Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive, Locally Advanced, or Metastatic Breast Cancer. J. Clin. Oncol., 32 (14). S. 1437 - 1446. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755